Seven ways to reduce infections among people who inject drugs: Joint guidance reportArchived
’Prevention of infections among people who inject drugs is achievable and effective – if it is properly executed’, stresses ECDC Director Marc Sprenger. In recent years, many European countries have achieved substantial progress in preventing drug-related infections. Drug injecting, however, remains a major cause of infectious diseases across Europe. The interventions proposed in the guidance report range from the supply of injection equipment, testing and vaccination to the treatment of infections and drug dependence. These are best applied in combination and ideally in the same venue for maximum effect.
In their guidance report Prevention and control of infectious diseases among people who inject drugs, the agencies explore good and evidence-based public health practices that can support effective policies to reduce infections. Common blood-borne viruses in this group include HIV, hepatitis B and C as well as tuberculosis. Launching the report during a meeting of infectious disease experts in Lisbon today, the two agencies aim to support countries across Europe in their efforts to reduce infection risks.
Half of all women with HIV are diagnosed late in Europe
28 Nov 2019 - Many women in the WHO European Region, particularly those in their 40s, are diagnosed at a late stage of HIV infection when their immune system is already starting to fail. They are three to four times more likely to be diagnosed late than younger women. According to data for 2018 released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe, women accounted for one-third of the 141 000 new HIV diagnoses in the Region, indicating that this population needs more attention in Europe's prevention and testing efforts.
Know your status: get tested during European Testing Week
22 Nov 2019 - On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
Around half a million men who have sex with men in the EU need PrEP but cannot access it
11 Oct 2019 - This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.